Juvenile Hyaline Fibromatosis synonyms

Juvenile Hyaline Fibromatosis (JHF) is a rare autosomal recessive disorder primarily known in modern medical literature as Hyaline Fibromatosis Syndrome (HFS). Due to its historical classification and evolving clinical understanding, it is frequently referenced by multiple synonyms, including Murray-Puretic-Drescher syndrome, which are essential for patients to recognize when searching medical records or historical research papers.

Why does Juvenile Hyaline Fibromatosis have so many names?

The naming of Juvenile Hyaline Fibromatosis has evolved as researchers realized that the condition exists on a clinical spectrum. Historically, milder forms were often categorized separately from more severe presentations. Today, medical professionals prefer the term Hyaline Fibromatosis Syndrome because it encompasses both Juvenile Hyaline Fibromatosis and the more severe infantile systemic hyalinosis (ISH), reflecting that these are variations of the same genetic condition caused by CMG2/ANTXR2 gene mutations.

What are the common synonyms and historical terms?

When reviewing clinical literature or older medical files, you may encounter several terms used to describe Juvenile Hyaline Fibromatosis. Understanding these synonyms ensures you can access comprehensive data across different databases:

• Hyaline Fibromatosis Syndrome (HFS) – The currently preferred clinical umbrella term.


• Murray-Puretic-Drescher Syndrome – An eponym often found in older dermatological literature.


• Juvenile Hyalinosis – A simplified historical reference.


• Infantile Systemic Hyalinosis – Often considered the severe end of the same genetic spectrum.

How is the condition classified officially?

In major medical classification systems, Juvenile Hyaline Fibromatosis is cataloged to facilitate international research and patient care. Its primary identifiers include:

• OMIM (Online Mendelian Inheritance in Man): #228600


• Orphanet: ORPHA334


• ICD-10: Classified under rare diseases affecting connective tissue.

Next steps

• Consult with a clinical geneticist to confirm the specific ANTXR2 mutation if you have received a diagnosis of Juvenile Hyaline Fibromatosis.


• Connect with the 7 members of the DiseaseMaps.org community who are currently sharing their personal experiences with Juvenile Hyaline Fibromatosis.


• Use the term "Hyaline Fibromatosis Syndrome" when searching clinical trial databases like ClinicalTrials.gov for the most up-to-date research results.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH GARD: Genetic and Rare Diseases Information Center (Hyaline Fibromatosis Syndrome).


• OMIM: Online Mendelian Inheritance in Man (Entry #228600).


• Orphanet: The portal for rare diseases and orphan drugs (ORPHA334).


• PubMed: Peer-reviewed literature on ANTXR2-related disorders.